x
- Home
- Diabetes Models
- In Vivo Models of Diabetes Mellitus
- In Vitro Models of Diabetes Mellitus
- Diabetes Drug R&D Services
- Therapeutic Areas
- Virtual Booth
- Company
Ace Therapeutics provides comprehensive preclinical development services for innovative antidiabetic drugs. Our experienced experts provide customized diabetes models, drug development services and expertise during the preclinical phase of antidiabetic drug development in order to help clients make informed decisions. Our professional services and reliable data are designed to help clients reduce drug development risks and accelerate their antidiabetic drug development programs.
After identifying the antidiabetic drug candidates, comprehensive pharmacokinetic, pharmacodynamic and safety related studies are required. Our main objective is to help our clients to obtain quality, effective and safe antidiabetic drugs for the following innovations in the field of diabetes.
Ace Therapeutics provides comprehensive preclinical research services for the development of different types of antidiabetic drugs. Our capabilities include in vivo and in vitro efficacy assessments, pharmacokinetic analyses and safety testing. We combine validated and well-characterized diabetes models with a variety of advanced technologies to enable comprehensive analysis of antidiabetic drug candidates. Our flexible and customizable services provide detailed preclinical data to ensure that clients make critical pipeline decisions based on accurate and reliable information.
Below are details of the services we provide during the process:
Ace Therapeutics has a well-established preclinical pharmacodynamics platform that provides comprehensive in vivo and in vitro pharmacodynamic assessment services. We conduct comprehensive pharmacodynamic studies using both whole and ex vivo approaches in a variety of validated diabetes models. We can provide professional technical support and solutions according to the different research needs of our clients. With our services, we can elucidate the efficacy of candidate antidiabetic drugs and their mechanism of action, thus providing a scientific basis for the effectiveness evaluation of new drugs.
We fully evaluate the absorption, distribution, metabolism and excretion characteristics of antidiabetic drug candidates in animals through in vitro ADME analysis and in vivo pharmacokinetic studies. Our customized strategies provide reliable pharmacokinetic data to help clients mitigate the risks associated with DMPK at an early stage, ensuring rapid and cost-effective advancement of antidiabetic drug development.
Ace Therapeutics offers a wide range of platforms and services to help you move from anti-diabetic drug discovery to preclinical research. If interested, please feel free to contact us. We will leverage our preclinical expertise to provide the services and support you need for your antidiabetic drug pipeline.
Ace Therapeutics has a team of experts in the field of endocrine and metabolic research, aiming to provide innovative preclinical contract research solutions to cope with diabetes and its complications. We provide customized solutions and technical support, enabling the transformation of promising concepts into innovative treatments, thus accelerating the drug development process of diabetes.
